Takeda Pharmaceutical Company Executive and Leadership Team

Milano Furuta, the Chief Financial Officer & Director at Takeda Pharmaceutical Company, directs the company's financial strategy and operations, ensuring fiscal health and sustainable growth. Furuta oversees all financial planning, budgeting, and reporting activities, providing critical insights to guide investment decisions in research, development, and market expansion. This leadership role is instrumental in managing the financial aspects of Takeda's diverse product portfolio, spanning gastroenterology, oncology, neuroscience, and rare diseases. By maintaining robust financial controls and driving strategic financial initiatives, Milano Furuta supports Takeda's commitment to delivering life-changing medicines and enhancing shareholder value. The financial acumen ensures resources are optimally allocated to achieve the company's long-term objectives.

Nory Shiokawa, the Senior VP & Chief Financial Officer, Growth & Emerging Markets Business Unit at Takeda Pharmaceutical Company, drives financial strategy and performance for key growth regions. Shiokawa manages financial planning, analysis, and reporting specifically tailored to the unique market dynamics of emerging economies, ensuring profitable expansion. This role is critical in allocating capital effectively to support Takeda's pharmaceutical product development and marketing efforts in these vital territories, focusing on areas like oncology and rare diseases. By providing strategic financial leadership, Nory Shiokawa enables Takeda to maximize its impact and reach in markets crucial for future growth, reinforcing the company's global healthcare mission.

Laura Pasternak, the Chief of Staff at Takeda Pharmaceutical Company, directs strategic initiatives and operational efficiency across various departments. Pasternak ensures seamless execution of high-priority projects, aligning departmental objectives with the company's overarching mission to deliver innovative pharmaceutical products. This leadership role involves coordinating cross-functional teams to enhance productivity and streamline workflows, particularly in the development and marketing of treatments for gastroenterology, oncology, neuroscience, and rare diseases. By fostering collaboration and driving accountability, Laura Pasternak supports the company's commitment to advancing healthcare solutions globally. The focus remains on optimizing internal processes to accelerate the delivery of life-changing medicines to patients worldwide.

Colleen Beauregard, the Vice President and Chief of Staff, Global Research and Development at Takeda Pharmaceutical Company, spearheads critical operational strategies within the R&D division. Beauregard oversees the coordination of global research efforts, ensuring alignment with the company's pipeline goals for oncology, neuroscience, and rare diseases. This involves managing complex project timelines, facilitating communication between research teams, and optimizing resource allocation to accelerate drug discovery and development. By driving efficiency in R&D operations, Colleen Beauregard directly contributes to Takeda's mission of bringing innovative medicines to patients. The strategic oversight ensures that scientific advancements translate into tangible therapeutic solutions, reinforcing Takeda's position in the pharmaceutical landscape.

Kelley Spring, the Executive Assistant To Chief Human Resources Officer at Takeda Pharmaceutical Company, provides essential support to the HR leadership, facilitating the smooth operation of human capital management. Spring manages critical administrative functions, ensuring efficient communication and coordination within the HR department and across other business units. This role is pivotal in supporting the strategic objectives related to talent acquisition, development, and retention, which are fundamental to Takeda's mission of delivering innovative healthcare solutions. By maintaining organizational efficiency and supporting key HR initiatives, Kelley Spring contributes to fostering a productive and supportive work environment essential for the company's continued success in pharmaceutical research and manufacturing.

Tracy Page, the Chief of Staff, Agile Operations Global Ethics & Compliance Head of Portfolio Management at Takeda Pharmaceutical Company, orchestrates critical operational functions and ensures adherence to ethical standards across global operations. Page leads portfolio management initiatives, driving efficiency and strategic alignment within agile operational frameworks. This involves overseeing compliance programs and managing key projects that support Takeda's mission to deliver innovative pharmaceutical products responsibly. By integrating ethical considerations with operational agility, Tracy Page strengthens Takeda's reputation and ensures sustainable business practices, contributing directly to the company's long-term success in healthcare.

Julian Harrison, the Global Chief of Staff, Legal at Takeda Pharmaceutical Company, directs strategic operations and enhances efficiency within the global legal department. Harrison oversees critical legal initiatives, ensuring robust compliance and effective risk management across all business functions, including pharmaceutical research and development. This role is vital in supporting Takeda's mission by safeguarding the company's legal integrity and facilitating the smooth execution of its global business strategies. By optimizing legal processes and fostering collaboration, Julian Harrison ensures that Takeda operates with the highest standards of corporate governance, supporting the delivery of innovative medicines worldwide.

Lindsay Gotts, the Chief of Staff Transformation Lead at Takeda Pharmaceutical Company, drives strategic transformation initiatives across the organization. Gotts spearheads efforts to modernize operations and enhance organizational agility, ensuring Takeda remains at the forefront of pharmaceutical innovation. This leadership role involves guiding change management processes and implementing new strategies that align with the company's mission to develop and deliver groundbreaking medicines for gastroenterology, oncology, neuroscience, and rare diseases. By focusing on continuous improvement and strategic evolution, Lindsay Gotts plays a key part in optimizing Takeda's capabilities to meet global healthcare challenges and improve patient outcomes.

Emily Welch, the HR Leader & Chief of Staff at Takeda Pharmaceutical Company, directs human resources strategy and operational support, ensuring alignment with the company's growth objectives. Welch oversees talent management, organizational development, and employee engagement initiatives, fostering a culture that supports innovation in pharmaceutical research and development. This role is critical in attracting, retaining, and developing the skilled workforce necessary to advance Takeda's mission of delivering life-changing medicines. By championing HR best practices and driving strategic people initiatives, Emily Welch contributes significantly to Takeda's ability to achieve its global healthcare goals and maintain a competitive edge.

Giovanna Krozel, the Global Procurement Strategic Initiatives Lead, Region Chief of Staff (US) at Takeda Pharmaceutical Company, manages critical procurement strategies and provides leadership support for US operations. Krozel drives initiatives to optimize sourcing and supply chain efficiency, ensuring the timely and cost-effective acquisition of resources essential for pharmaceutical manufacturing and development. This role is pivotal in supporting Takeda's mission by securing the necessary components and services that enable the production of vital medicines for gastroenterology, oncology, and rare diseases. By enhancing procurement processes and overseeing regional strategic alignment, Giovanna Krozel contributes to Takeda's operational excellence and its ability to serve patients effectively.